Danaher Corporation’s DHR share price has surged by 6.12%, which has investors questioning if this is right time to sell.

Analysts are estimating that Abbott Laboratories will report an earnings per share (EPS) of $1.07. The market awaits Abbott ...

Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced the publication of the TRANSCEND clinical trial, a global ...

ABT's Structural Heart, Rhythm Management and Neuromodulation businesses are likely to have driven its first-quarter 2025 performance.

They said the test, called “the Roche immunoassay,” was known to result ... which explain the hypoglycemia in both babies, such as line failure, sepsis and perinatal stress-induced ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $144.82, a high estimate of $160.00, and a low estimate of $135.00. This upward trend is apparent, with the ...

Letby, 35, from Hereford, is serving 15 whole-life orders after she was convicted across two trials at Manchester Crown Court ...

Over the last few years, viral diagnostics have made tremendous progress, pushed by the demands of fast and precise detection ...

To investigate the above-described controversy, we used lateral flow immunoassay (LFIA) technology to test for ... The capture Ab is immobilized on the test line of a nitrocellulose strip and ...